![Mark L. Peterson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Mark L. Peterson
Entité | Type d'entité | Industrie | |
---|---|---|---|
Cyclenium Pharma, Inc.
![]() Cyclenium Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cyclenium Pharma, Inc. is a privately held pharmaceutical research and development company based in Montréal, Canada. The Canadian company is focused on creating value through the progression of internal programs in oncology, infectious diseases, and inflammation/pain. Cyclenium is also providing its extensive experience and exploring its CMRT-based Quest™ screening library in risk-sharing partnerships with leading academic and research-driven non-profit organizations, as well as collaborations with innovative pharmaceutical and biotechnology companies worldwide seeking to modulate unique and difficult disease targets in diverse therapeutic areas. The company was founded by Mark L. Peterson, and the CEO is Helmut Thomas.
1
| Private Company | Pharmaceuticals: Major | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Mark L. Peterson via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
LymphoSign, Inc.
![]() LymphoSign, Inc. BiotechnologyHealth Technology LymphoSign, Inc. develops drugs for the cancer treatment. It also develops drugs acting on signaling pathways involved in the progression of acute leukemias, lymphomas and solid tumors. The company was founded by Chaim Roifman in 2000 and is headquartered in Markham, Canada. | Biotechnology | Chief Tech/Sci/R&D Officer | |
University of Hannover | College/University | Doctorate Degree | |
Novartis Pharma NV
![]() Novartis Pharma NV Pharmaceuticals: MajorHealth Technology Founded in 1996, Novartis Pharma NV is a Belgian pharmaceutical company that develops medicines. The company is based in Brussels, Belgium and is a subsidiary of Novartis AG. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
Etats-Unis | 3 |
Canada | 2 |
Allemagne | 2 |
Belgique | 2 |
Sectorielle
Health Technology | 5 |
Consumer Services | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 3 |
Doctorate Degree | 1 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Relations les plus connectées
Insiders | |
---|---|
Helmut Thomas | 6 |
- Bourse
- Insiders
- Mark L. Peterson
- Connexions Sociétés